Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 May 17;5(5):1648-59.
doi: 10.3390/nu5051648.

Inhibitory effects and mechanisms of luteolin on proliferation and migration of vascular smooth muscle cells

Dehua Jiang  1 , Dongye Li, Wanling Wu
Affiliations
Review

Inhibitory effects and mechanisms of luteolin on proliferation and migration of vascular smooth muscle cells

Dehua Jiang et al. Nutrients. .

Abstract

Atherosclerosis (AS) is a complicated progress, involving many types of cells. Although the exact mechanisms of progression of atherosclerosis are uncertain, the balance of vascular smooth muscle cells (VSMCs) proliferation and apoptosis appears to play a pivotal role in the pathogenesis and progression of atherosclerosis, and much discussion has been undertaken to elucidate the detailed mechanisms, relevant gene expression and transduction pathways. Drug treatment has focused on ameliorating atherosclerosis. Some researchers have indicated that inhibiting VSMCs proliferation is involved in attenuating atherosclerosis. Luteolin is a kind of flavonoids naturally occurring in many plants and possesses beneficial effects on cardiovascular diseases. Luteolin can reduce VSMCs' proliferation and migration and this reduction is stimulated by several factors. The aim of this review is to summarize the existing inhibitory effects and mechanisms of luteolin on proliferation and migration of VSMCs, and consider whether luteolin may be a potential candidate for preventing and treating atherosclerosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Possible mechanisms of luteolin inhibit vascular smooth muscle cells’ proliferation and migration. (AT 1R: angiotensin type 1 receptor; Lut: Luteolin).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Doran A.C., Meller N., McNamara C.A. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2008;28:812–819. doi: 10.1161/ATVBAHA.107.159327. - DOI - PMC - PubMed
    1. Wang C., Zhang Y., Yang Q., Yang Y., Gu Y., Wang M., Wu K. A novel cultured tissue model of rat aorta: VSMC proliferation mechanism in relationship to atherosclerosis. Exp. Mol. Pathol. 2007;83:453–458. doi: 10.1016/j.yexmp.2007.08.002. - DOI - PubMed
    1. Ross J.S., Stagliano N.E., Donovan M.J., Breitbart R.E., Ginsburg G.S. Atherosclerosis and cancer: Common molecular pathways of disease development and progression. Ann. N. Y. Acad. Sci. 2001;947:271–292; discussion 292–293. - PubMed
    1. Zernecke A., Weber C. Chemokines in the vascular inflammatory response of atherosclerosis. Cardiovasc. Res. 2010;86:192–201. doi: 10.1093/cvr/cvp391. - DOI - PubMed
    1. Boyle EM., Jr., Lille S.T., Allaire E., Clowes A.W., Verrier E.D. Endothelial cell injury in cardiovascular surgery: Atherosclerosis. Ann. Thorac. Surg. 1997;63:885–894. doi: 10.1016/S0003-4975(97)00057-X. - DOI - PubMed

MeSH terms

-